MedPath

Proximal Tibial Open Wedge Osteotomy. A Clinical Prospective, Randomized RSA-trial.

Phase 4
Completed
Conditions
Osteoarthritis, Knee
Interventions
Procedure: bonesubstitution (Calcibon, Iliac Crest Bonegraft, control)
Registration Number
NCT00319280
Lead Sponsor
Northern Orthopaedic Division, Denmark
Brief Summary

In the treatment of osteoarthritis of the medial compartment of the knee, Open wedge high tibial osteotomy is a good choice of treatment for the young and active patient.

However it leaves an open gap which has to be filled with a bone substitute and requires stable fixation.

Hitherto the golden standard has been autograft taken from iliac crest but there are donorsite related problems and limited amount available.

Recently injectable and resorbable calciumphosphate-cements have been introduced and used with promising results in fractures of the distal radius, calcaneus and lateral tibial condyle.

These new cements seem to be a good alternative to other bone substitutes providing high initial strength that might promote early mobilisation; it resorbs and promotes osteoconduction securing safe healing.

The aim of the present study is to evaluate whether there is any difference in clinical outcome, correction, stability and healing in open-wedge osteotomies with three different bone substitutes: Autograft from iliac crest and the injectable calciumphosphate-cement Calcibon and as control a group with an empty gap.

Osteosynthesis is performed with the Dynafix® system (EBI) The investigation is performed as a randomised prospective clinical trial including 45 patients with a planned 2 years follow-up period.

Clinical outcome is evaluated with: Hospital of special surgery score, KOOS, SF 12 and Lysholm score.

Routine standing x-rays is performed. Stability is assessed with Roentgen Stereophotogrammetric Analysis (RSA) that provides the opportunity of exact 3-dimensional measuring of eventual loss of correction.

This combined with urine and serum bone-healing markers gives a very precise picture of the healing in the bone-gap.

To asses the cartilage of the knee MRI is performed and biochemical markers fore Collagen type II degradation are measured.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • Osteoarthritis of medial compartment of the knee, Ahlbäck gr. 1-2
  • Candidate for proximal tibial medial open-wedge osteotomy
  • Signed informed consent
Exclusion Criteria
  • Prednisolone treatment.
  • NSAID treatment.
  • BMI > or = 35.
  • Previous surgery in lateral knee compartment.
  • Secondary Arthrosis following fracture(s) of the tibial condyle(s).
  • Lack of informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1bonesubstitution (Calcibon, Iliac Crest Bonegraft, control)Minced Iliac Crest autograft in osteotomysite
2bonesubstitution (Calcibon, Iliac Crest Bonegraft, control)Injectable calcium phosphate cement in osteotomysite
3bonesubstitution (Calcibon, Iliac Crest Bonegraft, control)Local autograft in the osteotomysite serves as control
Primary Outcome Measures
NameTimeMethod
Migration in mm measured with RSA (Roentgen Stereometric Analysis)postoperative, at 3 month, 1 and 2 years
Secondary Outcome Measures
NameTimeMethod
Hip-Knee-Ankle axis3 month, 1 and 2 years.
MR of the knee4 weeks preoperative, preoperative, at 1 and 2 years postoperative.
Markers of chondral degradationpreoperative, at 6 weeks, 3 month, 1 and 2 years postoperative
Markers of bone synthesis and degradationpreoperative, at 6 weeks, 3 month, 1 and 2 years postoperative
Clinical scores: KOOS, Lysholm, SF12, Knee ScorePreoperatively, Postoperatively, 6 weeks, 3 months, 1 year and 2 years
Histomorphometric evaluation of bone healing and osseous integration of cement1 year

Trial Locations

Locations (1)

Northern Orthopaedic Division, Klinik Farsoe, Aalborg University Hospital

🇩🇰

Farsoe, Northern Jutland, Denmark

© Copyright 2025. All Rights Reserved by MedPath